Matrigel Tunes H9 Stem Cell-Derived Human Cerebral Organoid Development

Area of Science:

• Developmental Biology
• Neuroscience
• Stem Cell Biology

Background:

• Human cerebral organoids (hCOs) are valuable models for studying human neurodevelopment.
• Matrigel, a complex extracellular matrix mixture, is widely used in hCO protocols but its specific roles are not fully understood.
• Matrigel delivery methods vary, impacting organoid development unpredictably.

Purpose of the Study:

• To investigate how Matrigel dosage and delivery method affect the development and composition of H9 stem cell-derived hCOs.
• To elucidate the mechanisms by which Matrigel influences hCO phenotypes.

Main Methods:

• Culturing human embryonic stem cells into cerebral organoids.
• Systematically varying Matrigel dosage and delivery methods (embedding vs. soluble).
• Analyzing organoid size, morphology, cell type composition, and gene expression, focusing on the BMP4 pathway.

Main Results:

• Matrigel exposure significantly influences hCO size, morphology, and cellular composition.
• Higher Matrigel concentrations increase the number of choroid plexus (ChP) cells.
• The increase in ChP cells is regulated by the BMP4 signaling pathway.

Conclusions:

• Matrigel's quantity and delivery method are critical factors in determining hCO development and phenotype.
• Understanding Matrigel's role is essential for standardizing hCO protocols and interpreting experimental results.
• This study provides insights into optimizing Matrigel application for controlled hCO development.